budesonide

Type: Keyphrase
Name: budesonide
First reported 4 hours ago - Updated 4 hours ago - 1 reports

Bifidobacterium breve and Lactobacillus rhamnosus treatment is as effective as budesonide at ...

Asthma is estimated to affect as many as 300 million people worldwide and its incidence and prevalence are rapidly increasing throughout the world, especially in children and within developing countries. Recently, there has been a growing interest in ... [Published 7thSpace - 4 hours ago]
First reported Apr 14 2014 - Updated 18 hours ago - 2 reports

Orion Corporation Receives First Marketing Authorisations For Bufomix Easyhaler® Product

Orion Corporation has received Irish and Hungarian marketing authorisation for Bufomix Easyhaler®, an inhaled budesonide-formoterol combination product indicated for asthma and chronic obstructive pulmonary disease (COPD). In this formulation, budesonide ... [Published BioSpace - 18 hours ago]
First reported Apr 15 2014 - Updated Apr 15 2014 - 1 reports

Different Childhood Asthma Phenotypes, Different Strategies

Reuters Health InformationBy Reuters StaffApril 14, 2014NEW YORK (Reuters Health) - Different childhood asthma phenotypes respond differently to inhaled anti-inflammatory medications, suggesting a need for differential treatment strategies, according ... [Published General Medicine eJournal - Apr 15 2014]
First reported Apr 13 2014 - Updated Apr 13 2014 - 1 reports

Asthma Control & Rescue

Should we consider combination therapy for dual purposes?By Danielle Kempton, DHSc, PA-C, and Jennifer Hastings, MSHS, PA-CView Comments (0)Print ArticlFacebook reddit Newsvine Del.icio.us DiggYahoo! Buzz LinkedIn StumbleUpon Google Bookmarks MixxSection ... [Published Advance for NPs and PAs - Apr 13 2014]
First reported Apr 09 2014 - Updated Apr 09 2014 - 1 reports

[Review] Inhaled corticosteroids in children: effects on bone mineral density and growth

Potent, topically active corticosteroids with minimum systemic activity have fewer adverse effects than do systemic corticosteroids, and can control both asthma and allergic rhinitis when given in recommended doses. However, study findings show that children ... [Published The Lancet Respiratory Medicine online - Apr 09 2014]
First reported Apr 08 2014 - Updated Apr 08 2014 - 1 reports

BUDESONIDE Capsule [Mylan Pharmaceuticals Inc.]

First reported Apr 02 2014 - Updated Apr 02 2014 - 1 reports

Patent Issued for Topical Corticosteroids for the Treatment of Inflammatory Diseases of the Gastrointestinal Tract

By a News Reporter-Staff News Editor at Biotech Week -- A patent by the inventors Dohil, Ranjan (San Diego, CA); Bastian, John (San Diego, CA); Aceves, Seema (La Jolla, CA), filed on November 12, 2008, was published online on March 25, 2014, according ... [Published HispanicBusiness.com - Apr 02 2014]
First reported Apr 01 2014 - Updated Apr 01 2014 - 1 reports

Budesonide Nebulization Added to Systemic Prednisolone in the Treatment of Acute Asthma in Children

Background:   Inhaled corticosteroids, known to be effective as a maintenance medication in chronic asthma, have also been suggested as a therapy for acute asthma when given at high doses.Methods:   A double-blind, randomized, placebo-controlled trial ... [Published CHEST - Apr 01 2014]
First reported Mar 31 2014 - Updated Mar 31 2014 - 1 reports

Budesonide/eformoterol combination inhaler as maintenance and reliever treatment in asthma

For patients with significant asthma, the use of budesonide/eformoterol as both maintenance and reliever treatment is similarly effective to other management strategies in the achievement of good asthma control, while also reducing episodes of poor control ... [Published Medicine Today - Mar 31 2014]
Entities: budesonide, Encumbrance
First reported Mar 26 2014 - Updated Mar 27 2014 - 1 reports

AZ buys out Sumitomo stake in Japan unit

AstraZeneca has acquired the remaining stake held in its Japanese unit by Sumitomo Chemical.In a brief statement, the Anglo-Swedish drugmaker noted that it is paying some 10 billion yen ($102 million) to buy the shares and get complete control of AstraZeneca ... [Published Pharma Times - Mar 26 2014]
First reported Mar 25 2014 - Updated Mar 25 2014 - 1 reports

Investigation Report on China Budesonide Market

PR NewswireDUBLIN, March 25, 2014DUBLIN Research and Markets (http://www.researchandmarkets.com/research/s3kv36/investigation) has announced the addition of the " " report to their offering.(Logo: http://photos.prnewswire.com/prnh/20130307/600769 )Asthma ... [Published Digital Journal - Mar 25 2014]
First reported Mar 21 2014 - Updated Mar 21 2014 - 1 reports

Budesonide/formoterol maintenance and reliever therapy in moderate-to-severe asthma: Effects on eosinophilic airway inflammation

Source: Allergy and Asthma Proceedings, Volume 35, Number 2, March/April 2014 , pp. 141-147(7)Publisher: OceanSide Publications, Inc||Buy & download fulltext article:ORPressing the buy now button more than once may result in multiple purchasesPrice: $39.50 ... [Published IngentaConnect Publication AAP - Mar 21 2014]

Quotes

"It is clear that no single feature is sufficient to characterize these groups" the researchers note
The drugs to be procured included "Aceclofenac Gel, Aspirin Tablets, Methyl Salicylate IP, Amoxycillin, Cefotaxime Sodium, Eucayptol IP, Ceftazadime Injection I P, Roxithromycin Suspension, Adapalene, Beclomethasone,  Chlorhexidine Gluconate Solution, Fusidic Acid Cream I P, Glutaraldehyde Solution, Ketoconazole Shampoo, Lidocaine Ointment, Insulin Injection (Human) I P, Pioglitazone Tablets I P, Glimeperide,  Metformin (SR), Ergotamine Tartate Tablets, Etoposide Capsulesules, Medroxyprogestrone Acetate, Tamoxifen Citrate, Ciprofloxacin Infusion, Dextrose (10D), Levofloxacin Infusion, Mannitol Infusion, Metronidazole Infusion, Sodium Chloride Infusion, Plasma Volume Expander (Gelatin Base), Albendazole, Dicyclomine 10 mg + Mefenamic Acid 250 mg Tablets, Diethylcarbamazine citrate Tablets, Famotidine Tablets, Lactic acid Bacillus, Ranitidine Injection, Calcium Citrate, Budesonide Respule, Pheniramine Maleate Tablets I P, Salbutamol Respule, Adenosine, Amiodarone , Clonidine Tablets, Clopidogrel, Diltiazem Tablets, Diltiazem Tablets, Enalpril Tablets, Frusemide Injection, Simvastatin Tablets, Tamsulosin Hydrochloride, Artesunate Tablets, Primaquine Tablets, Betahistine Tablets, Flunarzine Tablets, and Dexamethasone Tablets."
"In certain embodiments, provided herein is a method of treating, preventing or alleviating gastrointestinal inflammation or symptoms of gastrointestinal inflammation in an individual comprising orally administering to said individual a pharmaceutical composition comprising a corticosteroid, a liquid vehicle and a coating agent. In some embodiments, the esophageal inflammation is eosinophilic esophagitis, an inflammatory bowel disease involving the esophagus, Crohn's disease, esophageal inflammation secondary to caustic/irritant ingestion, persistent/recurrent esophageal strictures of any cause and including caustic/irritant ingestion, pill-induced esophagitis, systemic diseases, congenital diseases, post-surgery inflammation, or a combination thereof. In specific embodiments, the esophageal inflammation is eosinophilic esophagitis. In some embodiments, about 0.25 mg to about 10 mg corticosteroid per day is administered to the individual receiving treatment. In certain embodiments, the corticosteroid composition is administered once a day, or no moremore than once a day."

More Content

All (55) | News (36) | Reports (0) | Blogs (18) | Audio/Video (0) | Fact Sheets (0) | Press Releases (1)
sort by: Date | Relevance
Bifidobacterium breve and Lactobacillus rhamnos... [Published 7thSpace - 4 hours ago]
Orion Corporation Receives First Marketing Auth... [Published BioSpace - 18 hours ago]
Different Childhood Asthma Phenotypes, Differen... [Published General Medicine eJournal - Apr 15 2014]
Orion receives first marketing authorisations f... [Published GlobeNewswire: Advertising News - Apr 14 2014]
Orion receives first marketing authorisations f... [Published NASDAQ OMX - Apr 14 2014]
Asthma Control & Rescue [Published Advance for NPs and PAs - Apr 13 2014]
BPPI to procure 132 drugs from private cos to b... [Published PharmaBiz - Apr 09 2014]
[Review] Inhaled corticosteroids in children: e... [Published The Lancet Respiratory Medicine online - Apr 09 2014]
BUDESONIDE Capsule [Mylan Pharmaceuticals Inc.] [Published DailyMed Drug Label Updates for the last seven ... - Apr 08 2014]
Generic pains for AstraZeneca exacerbated by In... [Published Pharma Letter - Apr 07 2014]
Blog Post: Radiotherapy underway 4/33 to day 8/33 [Published Macmillan Cancer Support - Apr 04 2014]
Patent Issued for Topical Corticosteroids for t... [Published HispanicBusiness.com - Apr 02 2014]
Budesonide Nebulization Added to Systemic Predn... [Published CHEST - Apr 01 2014]
Theravance: Baby Thrown Out With The Bath Water... [Published Seeking Alpha - Mar 31 2014]
Budesonide/eformoterol combination inhaler as m... [Published Medicine Today - Mar 31 2014]
Coeliac disease - clinical review [Published GP Online - Mar 28 2014]
Use of a glucocorticoid composition for the tre... [Published PharmCast - Mar 28 2014]
AZ buys out Sumitomo stake in Japan unit [Published Pharma Times - Mar 26 2014]
Global Director Respiratory inhalation - Global... [Published PharmaDiversity - Mar 25 2014]
Investigation Report on China Budesonide Market [Published Digital Journal - Mar 25 2014]
Investigation Report on China Budesonide Market [Published PR Newswire: General Business - Mar 25 2014]
Investigation Report on China Rituximab Market,... [Published SBWire - Mar 24 2014]
Budesonide/formoterol maintenance and reliever ... [Published IngentaConnect Publication AAP - Mar 21 2014]
Medigene Has Completed [Published Investing.com - Mar 21 2014]
Drug-device convergence [Published PMLive - Mar 21 2014]
In brief: Brightree, ResMed rebrand and more [Published HME News - Mar 17 2014]
Pictorial case study - Nasal polyps [Published GP Online - Mar 14 2014]
Journals watch: Sleep apnoea | Inhaled corticos... [Published GP Online - Mar 14 2014]
Vectura Group plc : Acquisition of Activaero [Published Investegate - Mar 13 2014]
VECTURA GROUP PLC : Acquisition of Activaero [Published 4 Traders - Mar 13 2014]
1 2
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
[Review] Inhaled corticosteroids in children: e... [Published The Lancet Respiratory Medicine online - Apr 09 2014]
Potent, topically active corticosteroids with minimum systemic activity have fewer adverse effects than do systemic corticosteroids, and can control both asthma and allergic rhinitis when given in recommended doses. However, study findings show that children ...
BUDESONIDE Capsule [Mylan Pharmaceuticals Inc.] [Published DailyMed Drug Label Updates for the last seven ... - Apr 08 2014]
Updated Date: Apr 8, 2014 EST ...
Investigation Report on China Budesonide Market [Published PR Newswire: General Business - Mar 25 2014]
DUBLIN, March 25, 2014 /PRNewswire/ -- Research  and  Markets (http://www.researchandmarkets.com/research/s3kv36/investigation) has announced the addition of the "Investigation Report on China Budesonide Market" report to their... ...
Research and Markets: Investigation Report on C... [Published Business Wire Health News - Mar 10 2014]
DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/5rp48m/investigation) has announced the addition of the "Investigation Report on China Budesonide Market, 2009-2018" report to their offering. Asthma and allergic ...
[News] Moving beyond “me-too” respiratory drugs [Published The Lancet Respiratory Medicine online - Mar 10 2014]
European regulators have recommended approval of new respiratory drugs—four for chronic obstructive pulmonary disease (COPD) and two for treatment of both COPD and asthma, including a fixed-dose combination of inhaled anti-inflammatory budesonide and ...
1 2 3 4

Press Releases

sort by: Date | Relevance
Orion receives first marketing authorisations f... [Published GlobeNewswire: Advertising News - Apr 14 2014]
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.